HPV Vaccine: How Far have We Achieved?
نویسنده
چکیده
Globally, cervical cancer is the second most common cancer, and in India, it is the most common cancer in women. Human Papilloma virus (HPV) is the main cause of it. Although there are several methods for preventing cervical cancer, primary prevention by vaccination is the most effective option. HPV vaccine is safe and effective. It is expensive and is not a replacement for periodic cervical screening procedures. In developing countries, the cost effectiveness of vaccine and that of effective screening program with broader coverage is questionable. Today, HPV vaccine with regular cervical cancer screening program is the best possible tool to prevent cervical cancer.
منابع مشابه
Applying a Simple Model of Cost Effectiveness Study of HPV Vaccine for Iran
HPV vaccine has been recently added to the Iran Drug List, so decision makers need information beyond that available from RCTs to recommend funding for this vaccination. Modeling and economic studies have addressed some of those information needs. We reviewed cost effectiveness studies to find a suitable model for Iranian population to determine the potential cost effectiveness of HPV vaccine p...
متن کاملApplying a Simple Model of Cost Effectiveness Study of HPV Vaccine for Iran
HPV vaccine has been recently added to the Iran Drug List, so decision makers need information beyond that available from RCTs to recommend funding for this vaccination. Modeling and economic studies have addressed some of those information needs. We reviewed cost effectiveness studies to find a suitable model for Iranian population to determine the potential cost effectiveness of HPV vaccine p...
متن کاملPassed the Age of Puberty: Organizational Networks as a Way to Get Things Done in the Health Field; Comment on “Evaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda”
In this commentary I will demonstrate that the case study of Uganda’s Human papilloma virus (HPV) vaccine application partnership provides an excellent example of widening our lens by evaluating the successful HP vaccine coverage from a network-centric perspective. That implies that the organizational network is seen as the locus of production and that network theories become indispensable to a...
متن کاملCost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in Iran
Human Papilloma Virus (HPV) vaccine recently has been added to the Iran Drug List, decision makers need information beyond that available from RCTs to recommend funding for this vaccination program to add it to the National Immunization program in Iran. Modeling and economic studies have addressed some of those information needs in foreign countries. In order to determine the long term benefit ...
متن کاملPotentiation of human papilloma vaccine candidate using naloxone/alum mixture as an adjuvant: increasing immunogenicity of HPV-16E7d vaccine
Objective(s): Many types of human papillomaviruses (HPVs) have been identified, with some leading to cancer and others to skin lesions such as anogenital warts. Studies have demonstrated an association between oncogenic HPV and cervical cancer and many researchers have focused on therapeutic vaccines development. At present, the modulatory effect of opioids on the innate and acquired immune sys...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of obstetrics and gynaecology of India
دوره 64 5 شماره
صفحات -
تاریخ انتشار 2014